Delivery Order SPE2DB22D3501-SPE2DB25FXK62
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,741.91 to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Cryselle-28 tablets. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $1 billion and extending through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 13, 2025, for the supply of Cryselle-28 tablets, a birth control medication, with a ceiling value of $5,708.05. This is a firm fixed-price delivery order with an ultimate completion date of September 15, 2025, and represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child...
- This delivery order, awarded July 14, 2025, represents a $7,016.52 firm fixed-price contract issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Cryselle-28 tablets. The contract is set to be completed by July 15, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This award is a non-set-aside, competitively awarded contract that leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Cryselle-28 tablets (a contraceptive medication) under a firm fixed-price contract structure. The award, valued at $1,643.68, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, an approximately $1 billion prime vendor agreement running through December 2026. The delivery order carries no...
- The Defense Logistics Agency awarded a delivery order valued at $1,846.41 to AmerisourceBergen Drug Corp for Cryselle-28 tablets on July 23, 2025, with completion targeted for July 24, 2025. This firm fixed-price delivery order is not set-aside and represents a child contract under AmerisourceBergen's larger indefinite delivery vehicle with DLA. The product will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Cryselle-28 is an oral contraceptive...
- The Defense Logistics Agency awarded a delivery order valued at $7,221.73 to AmerisourceBergen Drug Corp for Cryselle-28 tablets on April 22, 2025, with an ultimate completion date of April 23, 2025. The contract employs firm fixed price pricing with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in Conshohocken, PA 19428....
- This is a $2,183.59 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CRYSELLE-28 TABLET 28S, a medical product, with a period of performance through April 15, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,556.30, is for the delivery of CRYSELLE-28 TABLET 28S, a pharmaceutical product, with a performance period through May 2, 2025. The contract is not set aside and was competitively awarded. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- This is a $19,107.06 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for CRYSELLE-28 TABLET 28S medical supplies, with a period of performance ending on February 2, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,089.41 Firm Fixed Price Delivery Order is for the supply of CRYSELLE-28 TABLET 28S, a pharmaceutical product. The contract has a period of performance through May 6, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FXK62Delivery Order
The Defense Logistics Agency (DLA) awarded a $2,624.07 firm fixed price delivery order to AmerisourceBergen Drug Corp for Cryselle-28 tablets (28-count packages) on September 18, 2025, with an ultimate completion date of September 19, 2025. This competitively awarded contract, with no set-aside designation, is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical supply transaction supporting the DLA Medical Supply Chain's mission to provision military and federal healthcare systems. Cryselle-28, an oral contraceptive, falls within the broad spectrum of pharmaceutical products AmerisourceBergen supplies through its comprehensive prime vendor agreement. The parent IDC serves as a flexible contract vehicle enabling AmerisourceBergen to fulfill diverse medical commodity requirements across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare customers on a global basis.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 9/18/25 |